Clofarabine in Adult Patients With Advanced Solid Tumors

PHASE1CompletedINTERVENTIONAL

Timeline

Start Date

August 31, 2002

Study Completion Date

August 31, 2007

Conditions

Solid TumorsLeukemia, Lymphocytic, Acute, PediatricLeukemia, Lymphocytic, Acute, AdultLeukemia, Myelocytic, Acute, PediatricLeukemia, Myelocytic, Acute, AdultMyelodysplastic Syndromes, Adult

Interventions

DRUG

clofarabine (IV formulation)

Trial Locations (2)

75246

Mary Crowley Medical Research Center, Dallas

75702

US Oncology Tyler Cancer Center, Tyler

All Listed Sponsors

lead

Genzyme, a Sanofi Company

INDUSTRY

NCT00125840 - Clofarabine in Adult Patients With Advanced Solid Tumors | Biotech Hunter | Biotech Hunter